Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
YESSSSSSSSSSSSSSSSSSSSSSSss
FLASR
19 min ·
The company is moving in a totally new business direction. Details to follow.
hope so
Investorshub newswire
"FLASR, Inc.
So it’s the week of “running stop signs”. Stop sign company FLASR, Inc. (OTC: FLSR) began trading to the tune of 1.6 billion shares between last Friday and yesterday. There is no website listed on OTC Markets, nor have they released any information by way of press or a filing in over a year. "
Hi
Could you give us Level 2 ask and bid ?
Tks a lot
Hi
What is the relationship with FLASR ?
Tks a lot
It's OK now
"Dec 14 (Reuters) - Diana Containerships Inc:
* MORGAN STANLEY REPORTS 5.3 PERCENT PASSIVE STAKE IN DIANA CONTAINERSHIPS INC AS OF DECEMBER 4 - SEC FILING Source: (bit.ly/2B1jtIQ) Further company coverage:"
Could you post a link to the news ?
I can't find it
Tks
Good evening
Could someone give me ask and bid ?
Tks a lot
Good morning
Is it possible to have current ask and bid ?
Tks
Resignation of the CEO (Cf twitter https://twitter.com/FlasrFlask)
OK tks a lot
What's a T Trade ?
Tks
How much is ask now ?
What's the interest to do a forward split when a share is valued 0,0001$ ?
Really I can't find
What's the reason for your optimism ?
What's new today ?
I can see only millions of shares sold
Great Basin Scientific Reports First Quarter 2017 Results
GlobeNewswire•May 22, 2017
Company continues to reduce operating expenses and cash burn
First quarter revenue increased 14% year-over-year
30% reduction in first quarter total operating expenses compared to fourth quarter
First quarter net income was $21.5 million; non-GAAP net loss improved 27% from the fourth quarter
Stool Bacterial Pathogens Panel under evaluation at over 40 customer sites ahead of anticipated FDA clearance
Very surprising :
volume 28,5 millions but only buy volume (sell volume = 0) !!
insert-text-here
Great Basin Scientific Announces Commercial Launch of Bordetella Direct Test
SALT LAKE CITY, May 16, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (GBSN), a molecular diagnostics company, today announced the U.S. commercial launch of its Bordetella Direct Test and its receipt of CE Marking designation under the European Directive on In Vitro Diagnostic Medical Devices. The Company received notification of 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the assay on March 31, 2017, approximately 57 days from submission. The Bordetella Direct Test expands Great Basin’s menu of commercially-available assays in the U.S. to five, and is the sixth assay to receive CE Marking under the European Directive on In Vitro Diagnostic Medical Devices.
“The processes we put in place that resulted in a swift FDA clearance also supported our ability to quickly commercialize the Bordetella Direct Test, much to the relief of many of our customers,” said Ryan Ashton, co-founder and chief executive officer of Great Basin. “Immediately after announcing FDA clearance, several hospitals contacted us requesting immediate access to the assay in order to respond to the testing demands from local pertussis outbreaks. We’re pleased to be able to respond quickly to support these hospitals and their patients with our easy-to-use, cost-effective, STAT solution for identifying this highly contagious and deadly disease. Bordetella Direct represents a continuation of our strategy to bring to market high value tests that we expect will improve gross margins as they become a significant part of our revenues, as we anticipate them to be.”
The Centers for Disease Control and Prevention (CDC) estimates that globally there are approximately 16 million cases of pertussis per year, with the disease being responsible for 195,000 deaths annually. Reported cases of pertussis in the U.S. have spiked since 1955, likely a result of declines in vaccine use, waning vaccine-induced immunity in adolescent and adult populations, and continued circulation of B. pertussis in the population. Given the gravity of the disease as well as its capacity for contagion, timely detection through PCR testing is essential in preventing the spread of disease and reducing the risk of widespread outbreaks. Great Basin’s Bordetella Direct Test allows random access (no need to batch) testing for B. pertussis without any sample preparation steps and at a considerably lower cost than large respiratory panels, providing results in under two hours.
“Currently, the most common route for Bordetella testing is to send specimens to a state or reference lab which, in the case of a reference lab, can be prohibitively expensive and cause several days – even weeks – delay in obtaining a result, during which time the patient may not be receiving appropriate treatment,” said Sandra Nielsen, senior vice president of sales and marketing for Great Basin. “While some labs have adopted molecular diagnostic testing for in-house Bordetella testing, their commercial options are a choice of expensive panels that test for a wide variety of unrelated respiratory issues or more cost-effective, but labor-intensive stand-alone tests. We believe that our solution offers the best of all worlds – an easy-to-use, cost-effective test that provides an answer in less than two hours. We’re pleased to be able to offer this assay to our customers, who have been awaiting its approval, so quickly after FDA clearance.”
In addition to its Bordetella Direct Test, Great Basin has commercial assays available for the detection of STEC, Group B Streptococcus (GBS), Toxigenic Clostridium difficile (C. diff), and a Staph Blood Culture Panel for identifying bloodstream infections caused by MRSA and other Staphylococcus species.
On april 10th 1st day after last reverse split (1/2000) :
open 6,75
hod 10,50
lod 2,48
close 2,50
With FDA 510K pending and without new reverse split it's seems possible to
find again at leat 4$
This seems very probable because before the last reverse split (1/2000) the stock price was 0,004 (so the equivalent of 8 after reverse split )
Because before split (1/2000) , 20 days ago , the last quotation was 0,004
And between this day and yesterday GBSN was GBSND
Fasten your seat belt
Direction the sky
What is the interest of a forward split with already so many shares ?
New site flasr.com
insert-text-here
A simple blog not related to FLASR
Same opinion for me
Less potential dilution = good news for shareholders
Same CEO but what is the link between the 2 companies ?
Curiously there are clearly more buyers than sellers
And this despite the disappointment linked to the absence of news announced
Interesting indeed
Tks a lot
Thanks but where have you found this information ?
OTC profile just now
insert-text-here
Only verified today
Can someone tell me what the meaning of these acronyms found in the order book Level 2 : CDEL CSTI NITE ETRF VNDM CANT MAXM
Thanks a lot
You break our feet
We are big enough to know what we have to do and we know very well why you are there
The good Samaritans on the stock market does not exist
Then let us go and see elsewhere
Where do you keep that information?
you know nothing more than us so your certainties ................
Not enough volume to drop its shares the CEO will be forced to tweet !!
The last 500 000 000 shares to drop (probably less) will require (pseudo) news
Instead of whining and complaining move your self and file a complaint
Must that only a Frenchman be capable of this?
It should be better if many people do the same
Complaint filed just now
Can someone answer these questions :
All of these new shares that enter the markets have been created with an private or public capital increase ?
When did it take place?
What was the purpose (weakness of the treasury ...)
Thanks a lot to those who will have the kindness to answer me
Unfortunatly no
Furthermore I'm french and live in France
It would be nice for others than me to threaten